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 1.  Introduction 
 Stimuli-responsive nanogels have 
gained signifi cant progress because of 
their great potential for applications 
in intelligent drug delivery and other 
biomedical fi elds. [ 1–4 ] Recently, much 
attention has been focused on the inte-
gration of stimuli-responsive polymer 
nanogels with inorganic nanoparticles 
(NPs) to combine the biosensing or bio-
imaging ability with the controlled drug 
delivery function. [ 5–10 ] A key attribute 
of such responsive hybrid nanogels as 
drug delivery systems is their ability to 
regulate the drug release under specifi c 
environments or stimuli, which can 
signifi cantly improve the therapeutic 
effi cacy at pathological sites but reduce 
the systemic side effects. [ 11 ] Both endog-
enous and exogenous activations can be 
used to regulate the drug release from 
their carriers. [ 12–14 ] The endogenous acti-
vation can be realized by the variation of 
specifi c physiochemical characteristics of 
the pathological microenvironment. [ 15–17 ] 
For example, many pathological pro-
cesses in tumor tissue and intracellular endosome/lyso-
some decrease the local pH by 1–2.5 pH units or increase 
the local temperature by 1–5 °C in comparison with that of 
blood and normal tissues. [ 18–20 ] On the other hand, the exog-
enous activation that can remotely control the drug release 
at a desired site and time is considered crucial to boost the 
drug effi cacy in cancer treatment while minimizing side 
effects. [ 21–26 ] Among all external stimuli including light and 
magnetic fi eld, near-infrared (NIR) light is the most favored 
for controlling the drug release due to its simple operation, 
low energy absorption, maximum penetration, and minimum 
side effects for human tissue and organs. [ 27,28 ] So far, nano-
structured gold (Au) has been commonly integrated into the 
stimuli-responsive polymer nanogels to realize simultaneous 
NIR light-triggered drug release and cell imaging. [ 29–34 ] How-
ever, several disadvantages are associated with the noble 
metal NPs for their use in biomedical areas, including the 
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toxicity for neuronal cells, potential induction of oxidative 
stress processes in the body, and high cost. [ 35,36 ] 
 Recently, small carbon dots (CDs) have received tremendous 
attention for their unique combination of excellent photosta-
bility, small size, biocompatibility, highly tunable photolumi-
nescence (PL) property, and chemical inertness. [ 37–48 ] Compared 
to noble metal NPs, CDs not only demonstrate lower toxicity 
and better biocompatibility according to their cytotoxic and in 
vivo toxic evaluation results but also possess many hydrophilic 
surface functional groups and thus can be easily dispersed in 
aqueous media without the need for further surface modifi ca-
tion. With these superior properties combined in a single dot, 
CDs have been recently evaluated as bioimaging agents. [ 41–47 ] 
In addition, CDs can be used for photothermal therapy and 
two-photon fl uorescent (TPF) imaging as a result of their 
absorption for NIR light and upconversion PL properties. [ 49–53 ] 
Considering the unique combination of these key material 
properties of CDs, it is desirable to integrate the CDs with bio-
compatible stimuli-responsive nanogels to develop a new type 
of multifunctional nanoplatform. It is expected that such inte-
grated hybrid nanogels can not only serve as an optical code 
for two-photon bioimaging and biosensing but also realize both 
endogenous and exogenous triggered drug release to enhance 
the therapeutic effi cacy. 
 Herein, we design a new class of biocompatible hybrid nano-
gels by immobilizing the fl uorescent CDs into biocompatible 
temperature/pH dual-responsive polymer nanogels for simul-
taneous fl uorescent pH sensing, TPF imaging, NIR light, and 
pH dual-responsive drug delivery. With a rational design on 
the compositions and properties of each building block, such a 
hybrid nanogel can be synthesized using a simple one-pot sur-
factant-free precipitation polymerization in water. Specifi cally, 
poly(ethylene glycol) (PEG) macromonomers and crosslinkers, 
chitosan chains, and CDs bearing surface hydroxyl/carboxyl 
groups were all dissolved in water. The hydroxyl/amine groups 
on the repeating units of chitosan chains, the surface hydroxyl/
carboxyl groups on CDs, and the ether oxygen on the PEG 
macromonomers can form hydrogen bonding associations or 
complexation. When these PEG macromonomers are poly-
merized and crosslinked, the chitosan chains will be physically 
entangled and interpenetrated in the resultant nonlinear PEG 
chain networks and the CDs will be in situ immobilized in the 
polymerized gel networks. These designed building blocks have 
not only excellent biocompatibility but also unique properties 
and functions. As schematically depicted in  Figure   1  , the newly 
designed hybrid nanogels combining the functional building 
blocks of fl uorescent CDs, thermoresponsive nonlinear PEG, 
and pH-responsive chitosan should provide great potential for 
biomedical applications. We demonstrate that the tri-compo-
nent hybrid nanogels, denoted as PEG-chitosan@CDs, display 
cooperative properties while maintaining the individual proper-
ties of each constituent, thus allowing the integration of several 
important functions. First, the chitosan-penetrated hybrid nano-
gels can not only sense the changes in environmental pH over 
the physiologically important range of 5.0–7.4 but also enable a 
biologically regulated release of the loaded anticancer drug Dox-
orubicin (DOX) due to the specifi c disruptions in the acid/base 
homeostasis of the local pathological environment (endogenous 
activation). Second, the hybrid nanogels composed of thermore-
sponsive nonlinear PEG network can trigger the drug release 
under the localized hyperthermia induced by an external irradi-
ation of NIR light benefi ted from the photothermal conversion 
ability of the embedded CDs (exogenous activation). In addi-
tion, the biocompatible hybrid nanogels can overcome cellular 
barriers to enter the intracellular region, which not only serve 
as a regular fl uorescent cellular imaging agent under an exci-
tation wavelength of 405 nm but also serve as a TPF imaging 
agent under an excitation wavelength of NIR light (900 nm). 
Such a multifunctional intelligent hybrid nanogel demonstrates 
a great promise toward the advanced nanoplatform for simulta-
neous medical diagnosis and high effi cacy therapy. 
 2.  Results and Discussion 
 The biocompatible PEG-chitosan@CDs hybrid nanogels are syn-
thesized by one-pot surfactant-free precipitation polymerization 
and crosslinking of the PEG comonomers [(2-(2-methoxy-
ethoxy)ethyl methacrylate (MEO 2 MA) and oligo(ethylene glycol) 
methyl ether methacrylate (MEO 5 MA)] complexed with chi-
tosan chains and CDs in water (pH ≈ 5.8) at 70.0 °C. While 
chitosan chains carry hydroxyl ( OH) and amine ( NH 2 ) 
groups in the repeating units, the CDs synthesized from the 
acid-assisted hydrothermal decomposition of glucose possess 
hydrophilic surface OH/ COOH groups (see Fourier trans-
form infrared, FTIR, spectrum of CDs at 3229 and 1708 cm −1 
in Figure S2 in the Supporting Information). It is expected 
that both the chitosan chains and CDs will complex with the 
MEO 2 MA and MEO 5 MA comonomers through the hydrogen 
bonding associations among the OH/ NH 2 groups of chi-
tosan, OH/ COOH groups of CDs, and the ether oxygens of 
the MEO 2 MA and MEO 5 MA monomers. [ 54 ] When these PEG 
macromonomers are polymerized and crosslinked, the com-
plexed chitosan chains and CDs will be in situ trapped in the 
resulted nonlinear PEG networks. The chitosan (p K a ≈ 6.2) with 
small degree ionization of the amine groups at the reaction 
medium can stabilize the resultant PEG-chitosan@CDs hybrid 
nanogel particles, thus no surfactant was needed for the syn-
thesis in water. A comparison of the FTIR spectra of the free 
CDs, PEG-chitosan nanogels, and PEG-chitosan@CDs hybrid 
nanogels (Figure S2, Supporting Information) indicates that 
the hybrid nanogels exhibit the characteristic peaks from both 
free CDs and PEG-chitosan nanogels.  Figure   2  A compares the 
typical UV–vis absorption spectra of the CDs, PEG-chitosan 
nanogels, and PEG-chitosan@CDs hybrid nanogels. While 
the PEG-chitosan nanogels have no signifi cant absorption at 
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 Figure 1.  Schematic illustration of biocompatible PEG-chitosan@CDs 
hybrid nanogel for multifunctional applications in biomedical fi eld, with 
CD representing for carbon dot.
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wavelength above 240 nm, the free CDs exhibit a clear broad 
peak centered at 240 nm, which represents the typical absorp-
tion of an aromatic Pi system and is similar to that of polycyclic 
aromatic hydrocarbons. [ 55 ] Compared to the free CDs and PEG-
chitosan nanogels, the synthesized hybrid nanogels show a 
similar absorption peak centered at 240 nm, indicating that the 
CDs have been successfully immobilized into the PEG-chitosan 
networks. When the aqueous dispersion of these hybrid nano-
gels was exposed to UV light (365 nm), green–blue light was 
obviously emitted (inset “a” in Figure  2 A). It should be men-
tioned that such designed PEG-chitosan@CDs hybrid nanogels 
have very stable optical property because of the in situ immo-
bilization of the CDs in the PEG-chitosan polymer network via 
hydrogen bonding interactions. No obvious fl uorescence inten-
sity change was observed after the hybrid nanogels were con-
tinuously dialyzed for 30 d against frequently changed water 
and (inset “b” in Figure  2 A). Figure  2 B shows a typical TEM 
image of the as-synthesized PEG-chitosan@CDs hybrid nano-
gels at dried state. The hybrid nanogels display a quasispherical 
morphology with an average diameter of about 182 nm and a 
remarkably heterogeneous structure with randomly dispersed 
dark spots/domains distributed in a relatively light-contrasted 
gray matrix. The dark spots/domains might be attributed to 
the individual and associated CDs embedded in the interior 
of poly mer networks. The highly magnifi ed sectional TEM 
image of a typical PEG-chitosan@CDs hybrid nanogel particle 
(Figure  2 C) confi rms that many black dots with size in a range 
of 3–10 nm are randomly distributed in the polymer matrix. 
The small black dots under high-resolution TEM exhibit a 
nanocrystal structure with 2D lattice fringes showing the inter-
planar distance of about 0.318 nm (Figure  2 D), which corre-
sponds to the (002) lattice planes of graphitic (sp 2 ) carbon. [ 56 ] 
These TEM results further confi rm that the graphitic CDs have 
been successfully immobilized into the PEG-chitosan networks. 
 We expect that the PEG-chitosan@CDs hybrid nanogels 
containing the ionizable NH 2 groups from the interpene-
trated chitosan chains should exhibit pH-responsive swelling/
deswelling transitions.  Figure   3  A shows the average hydrody-
namic diameter ( D h ) value of the resultant PEG-chitosan@
CDs hybrid nanogels dispersed in solutions of different pH 
values, measured at a scattering angle of  θ = 30° and the physi-
ological temperature of 37.0 °C. Clearly, the increase in the pH 
value of dispersion medium can gradually shrink the size of 
the PEG-chitosan@CDs hybrid nanogels with a dramatic size 
decrease occurring in the pH range of 5.0–6.2. It is understand-
able to observe this critical volume transition pH range for the 
PEG-chitosan@CDs hybrid nanogels. At pH below the p K a of 
chitosan (≈6.2), the NH 2 groups on the chitosan chains are 
protonated and positively charged, which produce strong Cou-
lomb forces. The mobile counterions cannot leave this phase 
to preserve the charge neutrality of the gel, therefore, produce 
full osmotic pressure for the gel to swell. [ 57 ] At pH below 5.0, 
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 Figure 2.  A) UV–Vis spectra of the CDs, PEG-chitosan nanogels, and PEG-chitosan@CDs hybrid nanogels. The insets a and b show photographs of 
the aqueous dispersions of the purifi ed hybrid nanogels under a UV light (365 nm) before and after 30 d dialysis; B) TEM image of the PEG-chitosan@
CDs hybrid nanogels; C) highly magnifi ed sectional TEM image of a typical PEG-chitosan@CDs hybrid nanogel; D) lattice fringe of a single CD under 
high resolution TEM.
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the NH 2 groups on the chitosan chains are nearly fully pro-
tonated, thus the hybrid nanogels swell to nearly a maximum 
degree. Based on this swelling mechanism, the PEG-chitosan 
nanogels prepared under the same conditions but without the 
addition of CDs exhibit a similar pH-dependent swelling curve 
to that of the PEG-chitosan@CDs hybrid nanogels. However, 
we found that the PEG-chitosan@CDs hybrid nanogels dis-
play larger sizes than the PEG-chitosan nanogels under all the 
measured pH values due to the successful embedding of the 
CDs in the PEG-chitosan@CDs hybrid nanogels. It should 
be mentioned that the resultant hybrid nanogels demonstrate 
a very narrow size distribution regardless of their swelling 
or shrinking states under different pH value, as shown in 
Figure  3 B. In addition, the surrounding temperature can fur-
ther manipulate the size of the PEG-chitosan@CDs hybrid 
nanogels (Figure  3 C). It is known that the nonlinear PEG 
chains can undergo a thermoresponsive volume phase transi-
tion as a consequence of the counterbalance of hydrophilic 
(PEG side chains) and hydrophobic (carbon backbone) forces 
in water. [ 58 ] For the PEG-chitosan@CDs hybrid nanogels, the 
critical volume phase transition temperature also depends on 
the pH-dependent ionization degree of the gel. The higher the 
ionization degree of the chitosan chains (e.g., pH below 5.0), 
the more hydrophilic of the hybrid nanogels, which requires 
a higher critical volume phase transition temperature for the 
nonlinear PEG networks chains to shrink. [ 59 ] At the body tem-
perature of 37.0 °C, the hybrid nanogels displayed an overall 
smaller swelling ratio at the physiological pH = 7.4 than at pH = 
5.0. These results indicate that the hydrogen-bonding associa-
tion and entanglement interactions not only enable the hybrid 
nanogels to exhibit pH/thermo dual-responsive phase behavior 
but also allow us to effectively modulate the pH response of the 
hybrid nanogels by applying cooling/heating strategy. 
 With the fl uorescent CDs successfully embedded into the 
PEG-chitosan networks, it is expected that the PEG-chitosan@
CDs hybrid nanogels will demonstrate the similar tunable and 
upconverted PL properties to the free CDs.  Figure   4  A shows 
the typical PL spectra of the PEG-chitosan@CDs hybrid nano-
gels under different excitation wavelengths ( λ ex ) in the UV–vis 
wavelength range. When the  λ ex increases from 260 to 520 nm, 
the emissions redshifted to longer wavelengths, which corre-
sponds to the different surface energy traps of the CDs. [ 60 ] The 
multiwavelength excitation spectra of the PEG-chitosan@CDs 
hybrid nanogels (Figure S3, Supporting Information) confi rm 
the different surface energy traps of these CDs. The maximum 
PL emission intensity locates at 477 nm, which was obtained 
with  λ ex = 400 nm. Figure  4 B shows the PL spectra of the PEG-
chitosan@CDs hybrid nanogels under the excitations in the vis–
NIR wavelength range. The upconverted emissions located in 
the range from 535 to 443 nm were clearly demonstrated when 
the  λ ex was applied from 980 to 620 nm, which should be attrib-
uted to the multiphoton active process similar to previously 
reported CDs. [ 61 ] In addition, the PEG-chitosan@CDs hybrid 
nanogels also exhibit excellent photostability. The PL spectra of 
the hybrid nanogels obtained under a continuous excitation of 
UV light ( λ ex = 360 nm) for 2 h (Figure S4A) change slightly. 
The maximum PL intensity obtained at emission wavelength 
( λ em ) of 450 nm decreases by ≈3.7% after 2 h continuous expo-
sure to the excitation light of 360 nm (Figure S4B, Supporting 
Information). All these results indicate that the as-obtained 
PEG-chitosan@CDs hybrid nanogels not only demonstrate 
 λ ex -tunable and upconverted PL properties but also show excel-
lent photostability against light illumination and air exposure, 
which is necessary for bioimaging and biosensing applica-
tions. Figure  4 C depicts the pH-dependent PL spectra of the 
hybrid nanogels obtained with  λ ex = 360 nm. It is clear that the 
increase in pH from 2.99 to 8.00 induces a signifi cant decrease 
in the PL intensity of the PEG-chitosan@CDs hybrid nanogels. 
Meanwhile, the emission peak also slightly redshifts from 438 
to 444 nm. As we previously discussed for Figure  3 A, the pH 
change of the dispersion medium can induce a volume phase 
transition of the hybrid nanogels. To visualize how the pH-
induced PL intensity change is correlated to the pH-induced 
volume phase transitions of the hybrid nanogels, we plotted the 
relative maximum PL intensity as a function of pH (Figure  4 D). 
Interestingly, the comparison of Figure  4 D with Figure  3 A indi-
cates that a conspicuous decrease in the PL intensity of the 
hybrid nanogels occurred at nearly the same pH range (5.0–6.2) 
as that of the gradual decrease in the size of the hybrid nano-
gels. This result implies that the PL quenching of the embedded 
CDs in the hybrid nanogels is caused by the pH-induced deioni-
zation shrinking of the PEG-chitosan nanogels. It has been 
reported that the PL of CDs is more of a surface process as a 
radiative recombination of the surface-confi ned electrons and 
holes instead of depending on sp 2 clusters in the core. [ 42,45 ] 
For example, the surface passivation with PEG polymer can 
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dramatically enhance the PL intensity of CDs. [ 62 ] For the same-
sized CDs, the overall PL properties of CDs are determined by 
the competition between the emissive sites and nonradiative 
trap sites on the surface. [ 47 ] In our PEG-chitosan@CDs hybrid 
nanogels, the CDs are immobilized in the polymer network via 
secondary force between their surface OH/ COOH groups 
and the OH/–NH 2 groups of chitosan chains as well as the 
ether oxygen of nonlinear PEG chains. At pH below 5.0, the fully 
protonated NH 3 + groups of the chitosan chains have strong 
electrostatic attractions with the dissociated surface COO − 
groups on CDs, thus surface of CDs is well passivated by the 
polymer chains. When the pH was increased from 5.0 to 6.2, the 
NH 3 + groups of chitosan gradually change to neutral NH 2 
groups, which reduce the electrostatic attractions between chi-
tosan chains and CDs. In other words, the chitosan chains are 
less attached on the surface of CDs when pH changes from 5.0 
to 6.2. The less passivated CDs may have more nonradiative trap 
sites and thus resulting in the quenched PL intensity. Since the 
pH-induced protonation/deprotonation of the NH 2 groups on 
chitosan chains is reversible, we expect that the quenched PL 
intensity should be recovered by changing the pH back to below 
5.0, at which the positively charged chitosan chains can passi-
vate the surface of CDs well. To examine the reversibility of the 
pH-induced PL change, the PL spectra of the PEG-chitosan@
CDs hybrid nanogels were measured for six cycles with a pH 
adjustment between 2.99 and 8.00 through centrifugation and 
redispersion in buffer solutions. As shown in Figure S5 (Sup-
porting Information), the maximum PL intensity of the hybrid 
nanogels is fully reproducible after the repeated acidifi cation 
and alkalization of the dispersion solutions, which indicates 
that the CDs have been stably immobilized in the PEG-chitosan 
chain networks. The reversible optical property change is critical 
for the hybrid nanogels to serve as a sensor. 
 After confi rming the strong fl uorescence and tunable emis-
sions of the PEG-chitosan@CDs hybrid nanogels, DU145 
human prostate cancer cells were selected as a model to eval-
uate the optical cellular imaging label function of these hybrid 
nanogels.  Figure   5  shows the laser scanning confocal images of 
the DU145 cells incubated with the PEG-chitosan@CDs hybrid 
nanogels under an excitation wavelength of 405 nm for dif-
ferent irradiation time. The PEG-chitosan@CDs hybrid nano-
gels emit a bright fl uorescence and can light up the DU145 
cells. In addition, the confocal images of DU145 cells did not 
show fl uorescent signal change after a continuous irradiation 
with the excitation laser at 405 nm for 30 min, which further 
indicates that the PEG-chitosan@CDs hybrid nanogels have 
excellent photostability and can be used for long-term cellular 
imaging. 
 Given the obviously observed upconverted PL properties in 
Figure  4 B, the TPF cell imaging ability of the PEG-chitosan@
CDs hybrid nanogels was expected.  Figure   6  shows the trans-
mission (A), TPF (B), and their overlaid (C) images of the 
DU145 human prostate cancer cells after uptaking the PEG-
chitosan@CDs hybrid nanogels upon an excitation by a fem-
tosecond infrared laser of 900 nm. It is clear that the cells can 
be illuminated by the upconverted fl uorescence emitted from 
the hybrid nanogels under the excitation of an NIR laser. In 
addition, the 3D cell imaging video (Figure S6, Supporting 
Adv. Funct. Mater. 2015, 25, 5537–5547
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Information) of the DU145 human prostate cancer cells incu-
bated with the hybrid nanogels demonstrates that the hybrid 
nanogels indeed enter into the intracellular region and have a 
high signal-to-noise ratio. The hybrid nanogels are distributed 
in the cytoplasm but not in the karyons. As the complexity of 
molecular interactions governing endocytosis is revealed, the 
mechanisms of endocytosis of the hybrid nanogels should 
be viewed in a broader context than simple vesicular traf-
fi cking. [ 63,64 ] All these results indicate that the PEG-chitosan@
CDs hybrid nanogels could be potentially used as a transmem-
brane drug carrier to release the drug molecules inside the 
tumor cells and realize a chemotherapy. The novel fl uorescent 
property of the PEG-chitosan@CDs hybrid nanogels offers a 
multiple-choice platform for biological labels. 
 The demonstrated pH-responsive volume phase transition 
and the endocytosis ability imply that the PEG-chitosan@CDs 
hybrid nanogels could be a promising smart drug carrier. Here, 
DOX is selected as an anticancer drug to test the drug-loading 
capacity and release behavior of the PEG-chitosan@CDs hybrid 
nanogels. Results show that the DOX molecules can be readily 
loaded into the PEG-chitosan@CDs hybrid nanogels by a simple 
mixing of the hybrid nanogels into the PBS solution of DOX. 
The DOX-loaded hybrid nanogels clearly demonstrate a UV–
vis absorption peak at around 480 nm from the characteristic 
absorption of DOX molecules (Figure S7, Supporting Informa-
tion). The quantitative analysis determines that the loading con-
tent of DOX in the PEG-chitosan@CDs hybrid nanogels and 
PEG-chitosan nanogels are 33 and 21 mg g −1 , respectively. This 
result indicates that the CD-containing hybrid nanogels have a 
much higher loading capacity for DOX drug molecules than the 
CD-free PEG-chitosan nanogels. This increased DOX loading 
capacity of the PEG-chitosan@CDs hybrid nanogels should be 
attributed to the conjugated aromatic carbon structures of the 
CDs embedded in the gel network, which can provide supramo-
lecular π stacking interactions with the DOX molecules and thus 
entrap more DOX molecules inside the polymer gel network. [ 65 ] 
 Figure   7  A shows the pH-responsive DOX releasing profi les 
from the PEG-chitosan@CDs hybrid nanogels obtained at dif-
ferent pH values of 5.0, 6.2, and 7.4, respectively. At the physi-
ological pH of 7.4, only 20.8% of loaded DOX was released from 
the hybrid nanogels at 37 °C after 96 h. With the pH decreased 
to 6.2, the amount of released DOX was increased to 25.4% after 
96 h. In contrast, the drug releasing rate at pH = 5.0 dramati-
cally increased. About 49.2% of the loaded DOX molecules could 
be released from the hybrid nanogels after 96 h, which indicates 
that the drug release rate can be easily regulated by varying the 
pH value of the releasing medium. The observed pH depend-
ency of the DOX releasing rate should be associated with a few 
factors. First, the decrease in pH from 6.2 to 5.0 induces the 
protonation of the NH 2 groups of chitosan chains and thus a 
swelling of the PEG-chitosan@CDs hybrid nanogels, which can 
provide more paths for the loaded DOX molecules to diffuse 
out from the gel network. Second, DOX is a weak amphipathic 
base with a p K a ≈ 8.2. The decrease in pH from 6.2 to 5.0 ena-
bles a more completed protonation of the NH 2 group on DOX 
molecules, which not only signifi cantly increases the solubility/
hydrophilicity of the DOX molecules but also increases the 
electrostatic repulsions between the DOX molecules and the 
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 Figure 5.  Laser scanning confocal microscopy images of DU145 human prostate cancer cells incubated with the PEG-chitosan@CDs hybrid nanogels 
(5 µg mL −1 ) under an excitation wavelength of 405 nm for different exposure time.
 Figure 6.  A) Transmission, B) two-photon fl uorescence, and C) overlaid images of DU145 human prostate cancer cells incubated with PEG-chitosan@
CDs hybrid nanogels. Excitation laser wavelength is 900 nm.
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chitosan chains in the nanogel drug carrier. Therefore, the DOX 
molecules have much higher mobility and thus can be released 
at a much faster rate at pH = 5.0 than at pH = 7.4 or 6.2. This 
pH-responsive drug releasing behavior is very important for 
an intelligent drug carrier because the microenvironments of 
extracellular tissues of tumors and intracellular lysosomes and 
endosomes are acidic, which can potentially facilitate an active 
drug release from the PEG-chitosan@CDs hybrid nanogels. [ 17,18 ] 
 Figure  7 B compares the DOX releasing profi les from the 
PEG-chitosan@CDs hybrid nanogels dispersed in PBS solu-
tion (pH = 7.4 and 5.0) at 37 °C with and without use of NIR 
light irradiation for 5 min at certain time points, respectively. 
Without the use of NIR irradiation, the release of DOX from the 
hybrid nanogels is slow and reaches a nearly steady rate after 
14 h. In contrast, 5 min irradiation of NIR light can signifi cantly 
speed up the release of DOX from the hybrid nanogels. When 
the NIR light was turned off, the drug release returns to its 
regular slow rate. Such a signifi cantly enhanced drug releasing 
rate under 5 min exposures to NIR light should be attributed to 
the local heat produced by the effi cient photothermal conver-
sion of the fl uorescent CDs embedded in the hybrid nanogels. 
Figure S8 in the Supporting Information confi rms the highly 
effi cient photothermal effect of the CDs exposed to NIR light 
at a power density of 1.5 W cm −2 . In the presence of 50 mg L −1 
of CDs, the temperature of water increases by ≈23 °C within 
5 min. In contrast, the temperature change of pure water (con-
trol) was much less signifi cant (≈8 °C) under the same irradia-
tion conditions. The NIR light-induced local heat produced by 
the CDs immobilized in the nanogels not only weakens the 
drug–host interactions (e.g., hydrogen bonding and π stacking, 
etc.) of DOX molecules with the CDs and PEG-chitosan net-
work chains but also increases the mobility of DOX at elevated 
temperatures. In addition, the elevated temperatures also 
induce a shrinkage of the PEG-chitosan@CDs hybrid nanogels, 
which can sequester out the loaded DOX molecules. This NIR 
light triggerable drug releasing rate from the PEG-chitosan@
CDs hybrid nanogels offers additional fast-acting dosage under 
NIR photoactivation when necessary, thus can further improve 
the therapeutic effi cacy when using the hybrid nanogels as a 
regular drug carrier for basal chemotherapy. 
 One advantage of the designed PEG-chitosan@CDs hybrid 
nanogels is their nontoxic materials. As shown in Figure  6 , 
no signs of morphological damage to the cells were observed 
upon treatment with the PEG-chitosan@CDs hybrid nanogels, 
thereby demonstrating their noncytotoxicity. The in vitro cyto-
toxicity results shown in  Figure   8  A further confi rm that the 
drug-free hybrid nanogels are nontoxic to the tested DU145 
human prostate cancer cells. More than 98% of the DU145 
human prostate cancer cells can survive upon 24 h treatment 
with the PEG-chitosan@CDs hybrid nanogels at concentrations 
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 Figure 7.  A) The pH-dependent release of DOX from the PEG-chitosan@CDs hybrid nanogels under different pH values (7.4, 6.2, or 5) at 37 °C; 
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up to 100 µg mL −1 even at pH = 5.0. In contrast, the cell viability 
drastically decreased when the cells were treated with the DOX-
loaded hybrid nanogels due to the drug effect of DOX mol-
ecules released from the hybrid nanogels. The pH-dependent 
drug releasing rates were also demonstrated on the cell viability 
test of the DOX-loaded hybrid nanogels. When the pH was 
decreased from 6.2 to 5.0, the DOX-loaded hybrid nanogels can 
kill the cancer cells much more effectively because more DOX 
molecules can be released from the gel network at pH = 5.0 
than at pH = 6.2 or 7.4. To investigate the photothermal effect 
of the hybrid nanogels, the DU145 cells were irradiated with 
1.5 W cm −2 NIR light for 5 min at a certain time point during 
the incubation process with the drug-free and DOX-loaded 
hybrid nanogels, respectively. As shown in Figure  8 B, the 5 min 
NIR irradiation alone only reduces a little bit on the viability of 
DU145 cells in normal culture medium when the hybrid nano-
gels carry no drug molecules. In contrast, the assistance of 5 
min NIR irradiation on the DOX-loaded hybrid nanogels can 
signifi cantly kill more tumor cells compared to the treatment 
without the use of 5 min NIR irradiation under the same con-
ditions. The enhanced cytotoxicity of the DOX-loaded hybrid 
nanogels with the 5 min NIR irradiation should be attrib-
uted to the synergistic effect of photothermo/chemotherapy. 
Although the NIR light-induced local heat produced from the 
CDs embedded in the interior of nanogels had no much direct 
damage on cells, the local heat can signifi cantly speed up the 
release of loaded DOX molecules to kill cancer cells. These 
results demonstrate that the PEG-chitosan@CDs hybrid nano-
gels as drug carriers can facilitate combined photothermal/
chemotherapy to provide high therapeutic effi cacy. 
 Figure   9  shows a comparison of the therapeutic effi cacies 
(calculated by subtracting the cell viability from 100%) from 
the combined chemo–photothermal treatment with the additive 
therapeutic effi cacies of independent chemo and photothermal 
treatments, which were estimated using the relation  T additive = 
100 − ( f chemo ×  f photothermal ) × 100, where  f is the fraction of sur-
viving cells after each treatment. [ 66 ] The therapeutic effi cacy of 
combined chemo–photothermal therapy with the DOX-loaded 
hybrid nanogels was signifi cantly higher than the additive 
therapeutic effi cacy of chemotherapy and photothermal therapy 
alone. When  t -test is used to compare the effi cacy of combined 
chemo–photothermal treatment with the additive effi cacies of 
independent chemo and photothermal treatments, all  p -values 
are lower than 0.01, indicating a signifi cant difference. Clearly, 
the PEG-chitosan@CDs hybrid nanogels as a drug carrier dem-
onstrated a highly synergistic effect of the combined chemo–
photothermal treatment and thus achieved a high therapeutic 
effi cacy, which will enable patients to lower down the dosage to 
reduce the systemic side effect. 
 In order to test the biocompatibility of the different sam-
ples in vivo, we performed histological analysis on various tis-
sues (kidney and liver) of mice injected with the drug-free and 
DOX-loaded hybrid nanogels at a concentration of 0.1 mg mL −1 , 
respectively, to identify any signs of acute toxicity. Tissues were 
harvested from mice 120 h after receiving the injection of 
hybrid nanogels, fi xed in 10% formalin, embedded in paraffi n, 
sectioned, and stained with hematoxylin and eosin (H&E). 
 Figure   10  shows the tissue sections from the injected and non-
injected mice. The review results by a pathologist with expertise 
in veterinary pathology indicates that the tissues obtained from 
the mice injected with drug-free hybrid nanogels appear similar 
to those tissues from noninjected control animals, showing no 
evidence of toxicity. However, the kidney tissues from the mice 
injected with the DOX-loaded hybrid nanogels showed that 
the impaired glomeruli are fi lled with bright red granular pro-
teinaceous material due to endothelial cell necrosis or sloughed 
pedicle, as well as necrosis of some hepatocytes, hydropic 
degeneration, and edema. The liver tissues obtained from the 
mice injected with DOX-loaded hybrid nanogels exhibit scat-
tered bile canaliculi and damage in septal between lobes of 
liver. These results indicate that the drug-free PEG-chitosan@
CDs hybrid nanogels are nontoxic and have good biocompat-
ibility. Meanwhile, these biocompatible hybrid nanogels can 
successfully carry drug molecules to tissues for chemotherapy. 
 3.  Conclusions 
 In summary, highly stable, biocompatible, and multifunc-
tional PEG-chitosan@CDs hybrid nanogels can be successfully 
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 Figure 9.  Therapeutic effi cacies of PEG-chitosan@CDs hybrid nanogels as a drug carrier and photothermal therapy agent at A) pH = 7.4 and B) pH = 5.0, 
respectively, for chemo, photothermal, and their combined treatments. The additive therapeutic effi cacies of independent chemo and photothermal 
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alone. All  p -values are lower than 0.01.
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synthesized using a simple one-pot surfactant-free precipita-
tion polymerization of PEG macromonomers complexed with 
chitosan chains and CDs. Combining the three functional 
building blocks, the PEG-chitosan@CDs not only maintain the 
properties from individual constituent but also display coop-
erative properties for simultaneous fl uorescent pH sensing, 
TPF cellular imaging, and pH/NIR light dual-responsive drug 
delivery. The embedded graphitic CDs with stable, excitation 
wavelength tunable, and upconverted PL properties not only 
provide the hybrid nanogels with high photothermal conver-
sion ability and TPF cellular imaging ability but also enhance 
the loading capacity of the hybrid nanogels for hydrophobic 
anticancer drug molecules. The hybrid nanogels can enter the 
intracellular region and light up tumor cells under the exci-
tations of both UV and NIR lasers. The pH-sensitive volume 
phase transition of the hybrid nanogels can facilitate an on-site 
pH-regulated drug release and modulate the surface properties 
of the embedded CDs to sense the environmental pH change 
over the physiologically important range of 5.0–7.4. Further-
more, the thermoresponsive properties of the hybrid nanogels 
can trigger the drug release under the irradiation of NIR light 
through the photothermal conversion ability of the embedded 
CDs. The hybrid nanogels enable a combined chemo–
photothermal treatment to provide a high therapeutic effi cacy 
due to their highly synergistic effect. While the drug-free hybrid 
nanogels are nontoxic, the drug-loaded hybrid nanogels can 
deliver drug effectively to the liver and kidney tissues of mice. 
Such a multifunctional nanoplatform has great potential for in 
vivo medical diagnostics and therapy. 
 4.  Experimental Section 
 Materials : D(t)-Glucose was purchased from ACROS, and all other 
chemicals were purchased from Aldrich. 2-(2-methoxyethoxy) ethyl 
methacrylate (MEO 2 MA, 95%), oligo (ethylene glycol) methyl ether 
methacrylate (MEO 5 MA,  M n = 300 gmol −1 ), and poly(ethylene glycol) 
dimethacrylate (PEGDMA,  M n ≈ 550 g mol −1 ) were purifi ed with neutral 
Al 2 O 3 . Chitosan was dissolved in acetic acid, then passed through a 
fi lter and dialyzed against distilled water for 3 d to remove free acetic 
acid. Doxorubicin hydrochloride, ammonium persulfate (APS), and HCl 
(37%) were used as received without further purifi cation. The water used 
in all experiments was of Millipore Milli-Q grade. 
 Synthesis of Fluorescent CDs : Fluorescent CDs were synthesized via an 
acid-assisted ultrasonic and thermal treatment of glucose. In a typical 
synthesis, glucose (2.70 g) was dissolved in deionized water (10 mL). 
After intense sonication for 20 min, 30.0 mL of HCl (37 wt%) was slowly 
added into the above solution. The mixed solution was then treated 
ultrasonically for 8 h and transferred into a 50 mL Tefl on-lined stainless 
autoclave. The precursor solution was heated to and maintained 
at 200 °C. After 24 h, the solution was cooled naturally to room 
temperature. The resulted CDs were purifi ed with repeated centrifugation 
and redispersion in water for three cycles so that larger CDs could be 
removed from products. Finally, the aqueous dispersion of CDs was 
dialyzed for 7 d (Spectra/Pormolecularporous membrane tubing, cutoff 
12 000–14 000) at room temperature (≈22 °C). The dialytic aqueous 
dispersion of CDs was then collected and dried to get solid CDs. 
 Surfactant-Free Synthesis of PEG-Chitosan@CDs Hybrid Nanogels : 
Typically, CDs (0.01 g), MEO 2 MA (1.34 × 10 −3 mol), MEO 5 MA 
(6.60 × 10 −4 mol), PEGDMA (6.00 × 10 −5 mol), and chitosan were 
dissolved in 198 mL deionized water (pH ≈ 5.8) in a 250 mL round-
bottom fl ask equipped with a stirrer, an N 2 gas inlet, and a condenser. 
The mixture was heated to 70.0 °C under an N 2 purge. After 1 h, APS 
(2 mL, 0.15  M ) was added to the mixture to initiate the polymerization 
reaction. The reaction was allowed to proceed for 5 h. The resultant 
reaction solution was centrifuged at 20 000 rpm (37 °C, 30 min, 
Thermo Electron Co. SORVALLRC-6 PLUS superspeed centrifuge) 
with the supernatant discarded and the precipitate redispersed in 
50 mL deionized water. After three repeated centrifugation/redispersion 
cycles, the resultant hybrid nanogel dispersion was diluted to a volume 
of 200 mL and then further purifi ed to remove possible remained 
monomer and free CDs by 7 d of dialysis (Spectra/Por molecular 
porous membrane tubing, cutoff 12 000–14 000) against very frequently 
changed water at room temperature (22 °C). The dialyzed water was 
monitored using UV–vis absorption spectrum. As shown in Figure S1 
(Supporting Information), the characteristic absorption peak of CDs 
gradually disappeared after a continuous dialysis against the frequently 
changed water. The free CDs in the hybrid nanogel dispersions can be 
completely removed after about 3–4 d. 
 Drug Loading and Release of PEG-Chitosan@CDs Hybrid Nanogels : 
DOX was loaded into the hybrid nanogels by complexation method. 
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 Figure 10.  Representative H&E stained tissue sections of mouse kidney and liver obtained from noninjected animals and from those injected with 
drug-free or DOX-loaded hybrid nanogels at a concentration of 0.1 mg mL −1 . The scale bar = 50 µm. The inset at the lower left corner in each image 
was enlarged from the black line framed section indicated by arrow.
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The hybrid nanogel dispersion (20 mL) placed in a vial was stirred 
in a water bath (10 °C) for 30 min. Then, DOX solution (2.0 mL, 
1.0 mg mL −1 , pH = 7.4) was added into the hybrid nanogel dispersion. 
After a continuous stirring for 24 h, the DOX-loaded hybrid nanogel 
complexes were then separated from the dispersion solution by 
centrifugation (37.0 °C, 20 000 rpm, and 30 min) and washed six times 
with distilled water to remove the unloaded DOX attached on the 
surface of hybrid nanogels. All the supernatant and washing solution 
was collected for the measurements of the drug loading content. The 
unloaded DOX presented in the supernatant was quantifi ed by a UV–vis 
spectrophotometer at 480 nm. The drug loading content of the hybrid 
nanogels was calculated by ( M 0 − M t )/ M N × 100%, where  M 0 and  M t are 
the total mass of DOX dissolved in the initial solution and remained 
in the supernatant solution, respectively.  M N is the mass of the dried 
nanogels used in the loading process. 
 The in vitro NIR light/pH-responsive release of DOX from the 
hybrid nanogels were evaluated by the dialysis method. The purifi ed 
DOX-loaded hybrid nanogels were redispersed in 25 mL PBS solution 
(0.005  M , pH = 7.4). First, two dialysis bags each fi lled with 5 mL diluted 
DOX-loaded hybrid nanogels were immersed in 50 mL 0.005  M buffer 
solutions of pH = 7.4 at 37 °C with one of them exposed to an NIR 
lamp of an output power of 1.5 W cm −2 for 5 min. Second, three dialysis 
bags each fi lled with 5 mL diluted DOX-loaded hybrid nanogels were 
immersed in 50 mL 0.005  M buffer solutions with different pH values 
(7.4, 6.2, and 5.0). The released DOX outside of the dialysis bag was 
sampled at defi ned time period and assayed by UV–vis spectrometry at 
480 nm. Cumulative release was expressed as the total percentage of 
drug released through the dialysis membrane over time. 
 Two-Photon Fluorescence (TPF) Cellular Imaging with PEG-Chitosan@
CDs Hybrid Nanogels as Labels : DU145 human prostate cancer cells 
were employed to evaluate the property of TPF imaging of the resultant 
PEG-chitosan@CDs hybrid nanogels. DU145 human prostate cancer 
cells were seeded into collagen-coated glass bottom dishes (MatTek) 
at a density of 4000 cells cm −2 . The cells were grown for 24 h before 
incubated with the PEG-chitosan@CDs hybrid nanogel particles. 
Hybrid nanogels were suspended in cell culture media by extensive 
ultrasonication for 30 min and adjusted to a fi nal concentration of 
5 µg mL −1 . The cells were then incubated with the hybrid nanogels 
overnight before imaging. Live-cell TPF images were obtained using 20X 
(dry) or 60X (water immersion) objectives on a Leica SP8 2-Photon/
FLIM confocal microscope equipped with an environmental chamber 
to maintain the experimental environment at 37 °C. The excitation 
wavelength was 900 nm for TPF imaging. 
 In Vitro Cytotoxicity Test of the Drug-Free and DOX-Loaded Hybrid 
Nanogels with or without NIR Irradiation : In this study, DU145 human 
prostate cancer cells were cultured in the 96 wells microplate in 
100 µL medium containing about 2000 cells seeded into each well. 
After an overnight incubation for attachment, the medium was removed 
and another 100 µL medium containing drug-free or DOX-loaded 
hybrid nanogels was added to make the fi nal exact concentrations of 
100 µg mL −1 , 75 µg mL −1 , 50 µg mL −1 , and 25 µg mL −1 , respectively. 
Wells that used the normal medium without any hybrid nanogels were 
used as control. For photothermal treatments, the cells were irradiated 
with 1.5 W cm −2 NIR light for 5 min in the middle of the incubation. 
After incubated for 24 h, 10 µL of 3-(4,5-dimethyl-2-thiazolyl)-2,5-
diphenyltetrazolium bromide (MTT) solution (5 mg mL −1 in PBS) is 
added into the wells, which were continuously incubated in a humidifi ed 
environment of 5% CO 2 and 37 °C for another 2 h. The medium were 
then removed and 100 µL of dimethyl sulfoxide solution is added. The 
plates were gently agitated until the formazan precipitate was dissolved, 
followed by measurement of optical density value by spectrophotometer 
at 570 nm and 690 nm. 
 Histopathological Evaluation : After an intracardial perfusion of 
buffered 10% formalin, whole organs (liver and kidney) of C57BL/6 mice 
were removed through necropsy and postfi xed in the same fi xative for 
48 h and embedded in paraffi n processed for histology, sliced into 5 µm 
sections, and stained with hematoxylin and eosin (H&E) according to 
standard clinical pathology protocols. A veterinary pathologist was then 
consulted to evaluate if any signs of acute toxicity were present in these 
clearance organs and cerebellum. Samples were submitted pathology 
assay 5 d after intravenous administration of drug-free hybrid nanogels 
( n = 3) and DOX-loaded hybrid nanogels ( n = 3) with a concentration of 
0.1 mg mL −1 and compared to both mice receiving no injection ( n = 3). 
 Characterization : Transmission electron microscopy (TEM) images 
were taken on a FEI TECNAI transmission electron microscope at 
an accelerating voltage of 100 kV. High-resolution TEM images were 
characterized by JEM 2100 with an acceleration voltage of 200 kV. The 
UV–vis absorption spectra were obtained on a Thermo Electron Co. 
Helios β UV–vis Spectrometer. The FTIR spectra were recorded with 
a Nicolet Instrument Co. MAGNA-IR 750 FTIR spectrometer. The UV 
light was provided by a 250 W high-pressure fl uorescent Hg lamp. 
The PL spectra were obtained on a JOBIN YVON Co. FluoroMax-3 
fl uorospectrometer equipped with a Hamamatsu R928P photomultiplier 
tube, calibrated photodiode for excitation reference correction from 200 
to 980 nm, and an integration time of 1 s. The photothermal experiments 
were conducted using a Philips infrared refl ector lamp with a power 
density of 1.5 W cm −2 and a fi lter to block ultraviolet light. Dynamic 
light scattering (DLS) was performed on a standard laser light scattering 
spectrometer (BI-200SM) equipped with a BI-9000 AT digital time 
correlator (Brookhaven Instruments, Inc.) to measure the hydrodynamic 
diameter ( D h ) distributions. An He–Ne laser (35 mW, 633 nm) was 
used as the light source. The hybrid nanogels dispersion was passed 
through Millipore Millex-HV fi lters with a pore size of 0.45 µm to remove 
dust before the DLS measurement. Confocal microscopic images were 
obtained using an Olympus Revolution XD Spinning Disk confocal 
microscope equipped with an environmental chamber to maintain the 
experimental environment at 37 °C. Diode laser with a wavelength of 
405 nm was used for the excitation. 
 Supporting Information 
 Supporting Information is available from the Wiley Online Library or 
from the author. 
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